J&J reported second quarter earnings Tuesday. The company is under scrutiny by investors as it faces drug patent cliffs.

UnitedHealth kicked off the year with a stark warning. In early January, management told investors to brace for rising ...

Justice Department prosecutors recently interviewed former employees about company practices that boost federal payments.

UnitedHealth Group is again responding to a Wall Street Journal story about billing practices for its Medicare Advantage plan ...

Wall Street indexes closed higher on Wednesday, led by the tech-heavy Nasdaq as Nvidia briefly reached a $4 trillion ...

(Reuters) -Investigators from the U.S. Department of Justice are questioning former employees of UnitedHealth Group as part ...

In an about-face, the administration is cracking down on so-called skin substitutes, overused treatments that cost Medicare ...

UnitedHealth Group stock declined on Wednesday following a report from the Wall Street Journal that ex-employees and medical ...

(PLD) on Wednesday reported a key measure of profitability in its second quarter. The results beat Wall Street expectations.

The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain ...

UnitedHealth is under federal investigation for Medicare billing practices, including use of nurses and software to log diagnoses that led to billions in extra payments.

The Department of Justice is interviewing former employees as part of its criminal Medicare fraud probe into UnitedHealth, according to ...